A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy

Summary

The purpose of this study is to evaluate the efficacy, safety and tolerability of palifermin on the incidence of oral mucositis in subjects with locally advanced head and neck cancer receiving postoperative radiotherapy.

Timeline

Start

2007-10

Primary completion

2008-09

Completion

2008-09

Outcome

Outcome not reported

Stopped: “The 20070201 study was terminated based on evaluation of Palifermin solid tumor data.”

Drugs

Indications